🔎 Trials Near Me

Home › Neuroblastoma › Michigan › Ann Arbor

Neuroblastoma clinical trials in Ann Arbor, MI

5 studies for Neuroblastoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RecruitingPhase 3
  • C S Mott Children's Hospital, Ann Arbor
Up to age 30 · All sexes · Updated Sep 24, 2026 · NCT06172296

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RecruitingPhase 3
  • C S Mott Children's Hospital, Ann Arbor
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • C S Mott Children's Hospital, Ann Arbor
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

RecruitingPhase 2
  • C.S Mott Children's Hospital, Ann Arbor
Ages 1 to 31 · All sexes · Updated Jul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

RecruitingObservational study
  • C.S Mott Children's Hospital, Ann Arbor
31 Days – 99 Years · All sexes · Updated Mar 23, 2026 · NCT01587300

About Neuroblastoma

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

More about Neuroblastoma on MedlinePlus

Neuroblastoma trials in other cities

Other studies in Ann Arbor

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.